摘要:
The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof.
摘要:
The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof.
摘要:
The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof.
摘要:
The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.
摘要:
Cyclohexane-1,2′-naphthalene-1′,2″-imidazole compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration, methods of therapy using such compounds, and pharmaceutical compositions containing such compounds.
摘要:
A package includes a top panel, a bottom panel, a first side panel connecting the top panel and the bottom panel to each other and a second side panel also connecting the top panel and the bottom panel to each other. The bottom panel, the first side panel, the top panel and the second side panel form a sleeve having a cross-section essentially formed as a rectangle. The sleeve is adapted to slidably receive an insert along a sliding direction normal to the rectangle. The package includes a locking member which includes an arch-shaped portion extending into the rectangular cross section to releasably retain the insert. The present disclosure also relates to a blank for forming the package.
摘要:
The invention relates to a method for limitation of at least one controllable operating parameter that can cause ageing of at least one component or one material in connection with an engine. The method includes the steps of determination of a maximum limit value allowed regarding the operating parameter and control of the engine so that the limit value is not exceeded, thereby limiting ageing of the component or material. The invention includes continuous determination of a measure that corresponds to the degree of impairment of the component that depends on ageing, wherein said determination of the limit value is made depending on the measure. The invention also relates to an arrangement for accomplishing this method. By means of the invention, an improved method and arrangement is provided for limitation of ageing of components and materials that, in particular, are arranged in connection with a combustion engine in a vehicle, thereby providing improved fuel consumption, improved emissions and improved performance of the vehicle.
摘要:
There is herein provided a compound of formula I (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1, R1, R2 and n have meanings as provided in the description.
摘要:
2H-imidazol-4-amine compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration. methods of therapy, and pharmaceutical compositions containing such compounds.
摘要:
A device for use with a lean-burning internal combustion engine is disclosed. The device is comprised of a means for generating an air/fuel mixture for the cylinders of the engine in order to provide at least stratified and homogenous operation, an exhaust system connected to the engine, and an NOX-adsorbing catalytic converter arranged in the exhaust system. The device additionally has a heat exchanger that is fitted upstream of the catalytic converter, wherein the heat exchanger is used to adapt the temperature of the exhaust gas from the engine to an operating state of the catalytic converter.